https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/amortization https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cash https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cash-uninsured-amount https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/damages-awarded-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-revenue-change https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-unrealized-losses-on-trading-securities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-goodwill https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/deposit-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/discontinued-operation-amount-of-adjustment-to-prior-period-gain-loss-on-disposal-net-of-tax https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/embedded-derivative-no-longer-bifurcated-amount-reclassified-to-stockholders-equity https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/eps https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/extraordinary-item-net-of-tax https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/fair-value-assets-and-liabilities-gain-loss-included-in-earnings https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/gain-loss-on-investments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/held-to-maturity-securities-accumulated-unrecognized-holding-gain https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/held-to-maturity-securities-accumulated-unrecognized-holding-loss https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/held-to-maturity-securities-amortized-cost-before-other-than-temporary-impairment https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/held-to-maturity-securities-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/held-to-maturity-securities-fair-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/held-to-maturity-securities-unrecognized-holding-loss https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/heldtomaturity-securities-unrecognized-holding-gain https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/incentive-from-lessor https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-before-extraordinary-items-and-cumulative-effect-of-change-in-accounting-principle https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-extraordinary-items-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-operations-before-extraordinary-items-per-basic-and-diluted-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-finished-goods-and-work-in-process-inventories https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/interest-income-other https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/interest-receivable-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/lease-incentive-payable-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/lease-incentive-receivable-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/legal-settlement-proceeds https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/license-costs https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/manufacturing-costs https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/marketable-securities-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/net-income https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-leases-income-statement-sublease-revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-commitment https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-deferred-costs-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-income https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-income-2 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-inventory https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-inventory-net-of-reserves https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/other-sales-revenue-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/payments-to-acquire-held-to-maturity-securities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-sale-and-maturity-of-held-to-maturity-securities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/public-float https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/restricted-stock-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/royalty-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/royalty-revenue https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sales-discounts-returns-and-allowances-goods https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-pos462b https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/share-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-option-plan-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/stockholders-equity-change https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/treasury-stock-shares-retired https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/treasury-stock-value https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/keryx-biopharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted